Pharmaceutical services firm ICON says that in the third three months of this year its net revenues grew 19% year on year to $339.8m.
Income from operations was $33.2m or 9.8% of revenue, compared to $20.9m or 7.3% for the same three months last year.
Year to date, to September, net revenues for 2013 increased 22% to $991m from $815m in 2012.
The company, which is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, upgraded it guidance for the full year 2013.
ICON's chief executive Ciaran Murray said: "We are raising our revenue guidance to the range of $1.325 -$1.330 billion and our earnings per share guidance to the range of $1.67-$1.70 for the financial year 2013."
The company is headquartered are in Dublin and overall the group operates from 77 locations in 38 countries and has approximately 10,300 employees.
It is listed in New York on the NASDAQ exchange.